Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Artificial Intelligence In Pathology Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for artificial intelligence in pathology has witnessed significant expansion in recent years. Its valuation is set to climb from $1.38 billion in 2025 to $1.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.4%. This past growth is largely attributable to the increasing digitization of pathology workflows, a heightened demand for precise cancer diagnostics, the expansion of pharmaceutical research activities, the adoption of digital slide scanners, and the growing availability of medical imaging datasets.
The artificial intelligence in pathology market is projected to experience substantial growth over the coming years. Its size is anticipated to reach $2.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. This projected growth during the forecast period is primarily driven by factors such as the expanding application of AI-assisted diagnostics, a heightened emphasis on personalized medicine, the broader incorporation of AI into clinical decision support systems, increasing investments in digital healthcare infrastructure, and a rise in regulatory approvals for AI-powered pathology instruments. Key trends expected during this period involve a greater adoption of AI-driven digital pathology platforms, an increased utilization of deep learning for tumor identification, the expanding integration of whole slide imaging systems, the growth of predictive analytics in diagnosing diseases, and an elevated focus on automating workflows within pathology laboratories.
Download A Free Sample Report For Comprehensive Market Insights:
#Artificial Intelligence In Pathology Market Growth Factors: Which Forces Are Supporting Market Expansion?
The growing demand for personalized medicine is anticipated to fuel the expansion of the artificial intelligence in pathology market. Personalized medicine involves customizing medical treatments and healthcare strategies to suit the distinct characteristics, requirements, and preferences of each patient. This rising demand stems from the ability to tailor treatments based on individual genetic profiles, lifestyle aspects, and specific disease traits, leading to enhanced effectiveness and fewer adverse reactions. Artificial intelligence (AI) within pathology facilitates personalized medicine by enabling more precise and efficient examination of medical images and genetic information. This, in turn, allows for more accurate diagnoses, improved identification of disease subtypes, and the development of customized treatment plans aligned with a patient’s unique biological makeup. As an illustration, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based professional membership organisation, revealed that in 2023, the US Food and Drug Administration (FDA) sanctioned 20 novel personalized medicines. This represented roughly 38 % of all newly approved therapeutic molecular entities, indicating a substantial rise from prior years. Consequently, the heightened requirement for personalized medicine is stimulating growth in the artificial intelligence in pathology market.
Artificial Intelligence In Pathology Market Segment Analysis Highlighting Growth Areas
The artificial intelligence in pathology market covered in this report is segmented –
1) By Component: Software, Scanners
2) By Neural Network: Generative Adversarial Networks, Convolutional Neural Networks, Conventional Neural Network, Recurrent Neural Networks, Other Neural Networks
3) By Application: Drug Discovery, Disease Diagnosis And Prognosis, Clinical Workflow, Training And Education
4) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories, Academic And Research Institutes
Subsegments:
1) By Software: Image Analysis Software, Diagnostic Workflow Software, Predictive Analytics Software
2) By Scanners: Whole Slide Imaging Scanners, Digital Pathology Scanners, Multi-Spectral Imaging Scanners
Artificial Intelligence In Pathology Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading firms within the artificial intelligence (AI) in pathology market are concentrating their efforts on creating sophisticated tools, notably multi-tissue cancer detection solutions, aimed at boosting diagnostic precision, optimizing operational processes, and achieving better patient results. These AI-powered multi-tissue cancer detection tools utilize foundation models and deep-learning algorithms to examine digitized pathology slides, facilitating the identification of cancer across various tissue types, encompassing both rare tumors and metastatic deposits. As an example, in January 2024, Paige, a digital pathology company based in the US, introduced a novel AI application constructed upon its Virchow foundation model, capable of identifying cancer in over 17 different tissue types. This solution is engineered to support pathologists by providing enhanced diagnostic accuracy, more rapid workflow efficiency, and practical insights crucial for individualized patient care.
Artificial Intelligence In Pathology Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc.
Access The Complete Artificial Intelligence In Pathology Market Report:
Artificial Intelligence In Pathology Market Global Footprint: Which Region Holds Market Leadership?
Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in pathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
